missing translation for 'onlineSavingsMsg'
Learn More
Learn More
EpCAM/TROP1 Antibody (323/A3), Allophycocyanin/Cy7 - (ECD), Novus Biologicals™
Mouse Monoclonal Antibody
Brand: Novus Biologicals NBP2-34532APCCY7
This item is not returnable.
View return policy
Description
EpCAM/TROP1 Monoclonal specifically detects EpCAM/TROP1 in Human, Rat (Negative) samples. It is validated for Flow Cytometry.
Specifications
| EpCAM/TROP1 | |
| Monoclonal | |
| APC-Cyanine7 | |
| PBS with 0.05% Sodium Azide | |
| EPCAM | |
| MCF-7 human breast cancer cells | |
| 0.1 mL | |
| Primary | |
| EGP40 is a 40-43kDa transmembrane epithelial glycoprotein, also identified as epithelial specific antigen (ESA), or epithelial cellular adhesion molecule (Ep-CAM). It is expressed on baso-lateral cell surface in most simple epithelia and a vast majority of carcinomas. This antibody has been used to distinguish adenocarcinoma from pleural mesothelioma and hepatocellular carcinoma. This antibody is also useful in distinguishing serous carcinomas of the ovary from mesothelioma. | |
| Store at 4°C in the dark. Do not freeze. |
| Flow Cytometry | |
| 323/A3 | |
| Flow Cytometry | |
| 17-1A, 323/A3, ACSTD1, antigen identified by monoclonal AUA1, CD326 antigen, Cell surface glycoprotein Trop-1, chromosome 4, surface marker (35kD glycoprotein), DIAR5, EGP, EGP-2, EGP314, EGP40, EpCAM, epithelial cell adhesion molecule, Epithelial cell surface antigen, Epithelial glycoprotein, Epithelial glycoprotein 314, ESA, GA733-2EGP34, hEGP314, HNPCC8, KS 1/4 antigen, KS1/4, KSAHEA125, M1S2, M4S1Ly74, Major gastrointestinal tumor-associated protein GA733-2, MIC18MH99, MOC31, TACST-1, TACSTD1, TROP1CD326, Tumor-associated calcium signal transducer 1CO-17A | |
| Mouse | |
| Protein A or G purified | |
| Cancer, Cancer Stem Cells, Tumor Biomarkers | |
| 4072.0 | |
| Human, Rat (Negative) | |
| IgG1 κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction